Works matching IS 00333158 AND DT 2004 AND VI 174 AND IP 1

Results: 17

The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia NMDA receptor and schizophrenia.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 32, doi. 10.1007/s00213-003-1709-2

By:

Coyle, Joseph T.;
Tsai, Guochuan

Publication type:

Article

Pharmacological manipulation of human working memory.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 126, doi. 10.1007/s00213-003-1732-3

By:

Barch, Deanna M.

Publication type:

Article

Pre-attentive processing and schizophrenia: animal studies.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 65, doi. 10.1007/s00213-003-1684-7

By:

Ellenbroek, Bart A.

Publication type:

Article

Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 143, doi. 10.1007/s00213-003-1673-x

By:

Lewis, David A.;
Volk, David W.;
Hashimoto, Takanori

Publication type:

Article

Adrenergic targets for the treatment of cognitive deficits in schizophrenia.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 25, doi. 10.1007/s00213-003-1724-3

By:

Arnsten, Amy F. T.

Publication type:

Article

Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia Working memory: the core cognitive deficit in schizophrenia.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 111, doi. 10.1007/s00213-003-1710-9

By:

Castner, Stacy A.;
Goldman-Rakic, Patricia S.;
Williams, Graham V.

Publication type:

Article

Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 17, doi. 10.1007/s00213-003-1683-8

By:

Roth, Bryan L.;
Hanizavareh, S. Mohammad;
Blum, Andrew E.

Publication type:

Article

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 54, doi. 10.1007/s00213-003-1750-1

By:

Martin, Laura F.;
Kem, William R.;
Freedman, Robert

Publication type:

Article

Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 39, doi. 10.1007/s00213-004-1792-z

By:

Moghaddam, Bita

Publication type:

Article

Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 45, doi. 10.1007/s00213-004-1794-x

By:

Friedman, Joseph I.

Publication type:

Article

Hippocampal function in cognition.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 99, doi. 10.1007/s00213-004-1795-9

By:

Sweatt, J. David

Publication type:

Article

The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 151, doi. 10.1007/s00213-003-1761-y

By:

Harrison, Paul J.

Publication type:

Article

Practice, learning, and the likelihood of making an error: how task experience shapes physiological response in patients with schizophrenia.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 136, doi. 10.1007/s00213-004-1834-6

By:

Holcomb, Henry H.

Publication type:

Article

Psychopharmacological approaches to modulating attention in the five-choice serial reaction time task: implications for schizophrenia.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 86, doi. 10.1007/s00213-004-1805-y

By:

Chudasama, V.;
Robbins, T. W.

Publication type:

Article

Measurement and treatment research to improve cognition in schizophrenia: neuropharmacological aspects.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 1, doi. 10.1007/s00213-004-1846-2

By:

Ceyer, Mark A.;
Tamminga, Carol A.

Publication type:

Article

Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 75, doi. 10.1007/s00213-004-1848-0

By:

Braff, David L.;
Light, Gregory A.

Publication type:

Article

Targeting the dopamine D<sub>1</sub> receptor in schizophrenia: insights for cognitive dysfunction.

Published in:

Psychopharmacology, 2004, v. 174, n. 1, p. 3, doi. 10.1007/s00213-004-1793-y

By:

Coldman-Rakie, Patricia S.;
Castner, Stacy A.;
Svensson, Torgny H.;
Siever, Larry J.;
Williams, Graham V.

Publication type:

Article